Surowiecka-Pastewka Agnieszka, Matejak-Górska Marta, Frączek Michał, Sklinda Katarzyna, Walecki Jerzy, Durlik Marek
Department of Gastroenterological Surgery and Transplantation, Medical Centre of Postraguade Medicine, Warsaw, Poland.
Department of Surgical Research and Transplantology, Mossakowski Medical Research Center of the Polish Academy of Sciences, Warsaw, Poland.
Ann Transplant. 2019 Apr 12;24:199-207. doi: 10.12659/AOT.912005.
BACKGROUND Vascular failures are serious complications in pancreas transplantation. Open surgery is a reliable and quick intervention method, but it carries a risk of infection and bleeding. Endovascular procedures are rare among patients after a SPK, but are becoming more frequently used. One of the main risks of the endovascular approach is that the renal function impairment caused by contrast agent. MATERIAL AND METHODS We performed a retrospective analysis of 200 transplanted pancreases at our center over the last 14 years. The analyses included those patients after pancreas transplantation who required the most challenging vascular interventions and ones that were non-standard for the procedure. RESULTS Severe vascular conditions requiring endovascular intervention were observed in 3% of SPKs. In one retransplanted patient, there was an acute ischemia of the lower extremity due to the narrowing of the common iliac artery following a previous transplantectomy, above the new pancreas graft anastomoses. In another patient, local inflammation led to the disruption of the external iliac artery on the level of transplantectomy, caused severe bleeding, and we had to implement a stent-graft to reconstruct the iliac artery wall. A third patient had a pseudoaneurysm demanding further treatment with a stent-graft implemented into the femoral artery due to a pseudoaneurysm of the right external iliac artery. CONCLUSIONS Intravenous interventions in patients with a transplanted or retransplanted pancreas are safe and feasible. It is a technically demanding procedure, but the risk of kidney graft function deterioration, as well as of bleeding due to the high dose of heparin used, is lower than with open vascular surgery.
背景 血管并发症是胰腺移植中的严重问题。开放手术是一种可靠且快速的干预方法,但存在感染和出血风险。血管内介入手术在胰肾联合移植(SPK)患者中较少见,但使用频率正逐渐增加。血管内介入方法的主要风险之一是造影剂导致的肾功能损害。
材料与方法 我们对本中心过去14年中200例胰腺移植病例进行了回顾性分析。分析对象包括胰腺移植后需要最具挑战性的血管介入以及手术过程不标准的患者。
结果 在3%的胰肾联合移植患者中观察到需要血管内介入的严重血管状况。在1例再次移植患者中,由于先前移植切除术后髂总动脉狭窄,在新胰腺移植吻合口上方,出现了下肢急性缺血。在另1例患者中,局部炎症导致移植切除水平的髂外动脉破裂,引起严重出血,我们不得不采用覆膜支架修复髂动脉壁。第3例患者因右髂外动脉假性动脉瘤,需要通过在股动脉植入覆膜支架进行进一步治疗。
结论 对移植或再次移植胰腺的患者进行血管内介入手术是安全可行的。这是一项技术要求较高的手术,但肾移植功能恶化以及因使用高剂量肝素导致出血的风险低于开放血管手术。